Search research articles
Contact Us
Filters
Showing results (611-620 of 634) with videos related to
Page
of 64
Sort By:
The American Journal of Pathology
|
February 27, 2007
Hypermethylation of RASSF1A in human and rhesus placentas
Rossa W K Chiu, Stephen S C Chim, Ivy H N Wong, et al.
European Journal of Haematology
|
July 13, 2023
Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect study
Mary Mathias, Aby Abraham, Mark J Belletrutti, et al.
Cell Reports
|
August 14, 2020
A Three-Way Combinatorial CRISPR Screen for Analyzing Interactions among Druggable Targets
Peng Zhou, Becky K C Chan, Yuk Kei Wan, et al.
International Journal of Molecular Sciences
|
April 23, 2022
Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid Carcinoma
Julia C Thierauf, Alex A Farahani, B Iciar Indave, et al.
Thrombosis and Haemostasis
|
February 13, 2021
Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study
Ri J Liesner, Aby Abraham, Carmen Altisent, et al.
Oncogene
|
December 2, 2010
FGF8b oncogene mediates proliferation and invasion of Epstein-Barr virus-associated nasopharyngeal carcinoma cells: implication for viral-mediated FGF8b upregulation
V W Y Lui, D M-S Yau, C S-F Cheung, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
August 18, 2017
Immunogenicity, efficacy and safety of Nuwiq<sup>®</sup> (human-cl rhFVIII) in previously untreated patients with severe haemophilia A-Interim results from the NuProtect Study
R J Liesner, M Abashidze, O Aleinikova, et al.
Histopathology
|
July 18, 2002
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases
S A Pileri, T M Grogan, N L Harris, et al.
Blood Advances
|
May 27, 2025
American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients
Paul Monagle, Muayad Azzam, Rachel Bercovitz, et al.
The Lancet. Haematology
|
November 9, 2019
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial
Christoph Male, Anthonie W A Lensing, Joseph S Palumbo, et al.
Page
of 64
Search research articles
Search
Showing results (611-620 of 634) with videos related to
Sort By:
Page
of 64
The American Journal of Pathology
|
February 27, 2007
Hypermethylation of RASSF1A in human and rhesus placentas
Rossa W K Chiu, Stephen S C Chim, Ivy H N Wong, et al.
European Journal of Haematology
|
July 13, 2023
Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect study
Mary Mathias, Aby Abraham, Mark J Belletrutti, et al.
Cell Reports
|
August 14, 2020
A Three-Way Combinatorial CRISPR Screen for Analyzing Interactions among Druggable Targets
Peng Zhou, Becky K C Chan, Yuk Kei Wan, et al.
International Journal of Molecular Sciences
|
April 23, 2022
Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid Carcinoma
Julia C Thierauf, Alex A Farahani, B Iciar Indave, et al.
Thrombosis and Haemostasis
|
February 13, 2021
Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study
Ri J Liesner, Aby Abraham, Carmen Altisent, et al.
Oncogene
|
December 2, 2010
FGF8b oncogene mediates proliferation and invasion of Epstein-Barr virus-associated nasopharyngeal carcinoma cells: implication for viral-mediated FGF8b upregulation
V W Y Lui, D M-S Yau, C S-F Cheung, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
August 18, 2017
Immunogenicity, efficacy and safety of Nuwiq<sup>®</sup> (human-cl rhFVIII) in previously untreated patients with severe haemophilia A-Interim results from the NuProtect Study
R J Liesner, M Abashidze, O Aleinikova, et al.
Histopathology
|
July 18, 2002
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases
S A Pileri, T M Grogan, N L Harris, et al.
Blood Advances
|
May 27, 2025
American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients
Paul Monagle, Muayad Azzam, Rachel Bercovitz, et al.
The Lancet. Haematology
|
November 9, 2019
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial
Christoph Male, Anthonie W A Lensing, Joseph S Palumbo, et al.
Page
of 64